HNF1B and ovarian serous carcinoma: Davidson et al advocated the central part of HNF1B marker in serous effusion diagnosis, with the data suggesting HNF1B to be an important biomarker which may differentiate CCC from serous ovarian carcinoma and cells of mesothelial origin.128